Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, United States; Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA, United States.
Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, United States.
Neurotoxicology. 2018 Jul;67:121-128. doi: 10.1016/j.neuro.2018.05.003. Epub 2018 May 18.
Methamphetamine (MA) exposure may increase the risk of motor or cognitive impairments similar to Parkinson's disease (PD) by middle age. Although damage to nigrostriatal or mesoaccumbens dopamine (DA) neurons may occur during or early after MA exposure, overt PD-like symptoms at a younger age may not manifest due to compensatory mechanisms to maintain DA neurotransmission. One possible compensatory mechanism is increased tyrosine hydroxylase (TH) phosphorylation. In the rodent PD 6-OHDA model, nigrostriatal lesion decreases TH protein in both striatum and substantia nigra (SN). However, DA loss in the SN is significantly less than that in the striatum. An increase in ser31 TH phosphorylation in the SN may increase TH activity in response to TH loss. To determine if similar compensatory mechanisms may be engaged in young mice after MA exposure, TH expression, phosphorylation, and DA tissue content were evaluated, along with dopamine transporter expression, 21 days after cessation of MA (24 mg/kg, daily, 14 days). DA tissue content was unaffected by the MA regimen in striatum, nucleus accumbens, SN, or ventral tegmental area (VTA), despite decreased TH protein in SN and VTA. In the SN, but not striatum, ser31 phosphorylation increased over 2-fold. This suggests that increased ser31 TH phosphorylation may be an inherent compensatory mechanism to attenuate DA loss against TH loss, similar to that in an established PD model. These results also indicate the somatodendritic compartments of DA neurons are more vulnerable to TH protein loss than terminal fields following MA exposure.
甲基苯丙胺(MA)暴露可能会增加中年时出现类似帕金森病(PD)的运动或认知障碍的风险。虽然 MA 暴露期间或早期可能会对黑质纹状体或中脑伏隔核多巴胺(DA)神经元造成损伤,但由于维持 DA 神经传递的代偿机制,年轻时可能不会出现明显的 PD 样症状。一种可能的代偿机制是增加酪氨酸羟化酶(TH)磷酸化。在啮齿动物 PD 6-OHDA 模型中,黑质纹状体损伤会降低纹状体和黑质(SN)中的 TH 蛋白。然而,SN 中的 DA 损失明显小于纹状体。SN 中 ser31 TH 磷酸化的增加可能会增加 TH 活性以应对 TH 损失。为了确定 MA 暴露后年轻小鼠是否可能参与类似的代偿机制,评估了 TH 表达、磷酸化和 DA 组织含量,以及多巴胺转运蛋白表达,在 MA 停药 21 天后(24mg/kg,每日,14 天)。尽管 SN 和 VTA 中的 TH 蛋白减少,但 MA 方案对纹状体、伏隔核、SN 或腹侧被盖区(VTA)中的 DA 组织含量没有影响。在 SN 中,但不在纹状体中,ser31 磷酸化增加了两倍多。这表明增加的 ser31 TH 磷酸化可能是一种内在的代偿机制,可减轻 TH 损失对 DA 损失的影响,类似于已建立的 PD 模型。这些结果还表明,与 MA 暴露后 DA 神经元的终端场相比,TH 蛋白损失更易发生在 DA 神经元的树突和胞体区。